drug
romidepsin
Marketedupdated 4mo agoby Fresenius Kabi USA LLC
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Trials studying romidepsin
- phase3Efficacy and Safety of Oral Azacitidine Compared to Investigator's Choice Therapy in Patients With Relapsed or Refractory AITL
- phase1Romidepsin, Gemcitabine, Dexamethasone and Cisplatin in the Treatment of Peripheral T-Cell and Diffuse Large B-Cell Lymphoma
- phase1Study Investigating Intravesical HDAC Inhibition to Improve Response to Immuno-Oncology Agents
- phase2Randomized Phase IIB Trial of Oral Azacytidine Plus Romidepsin Versus Investigator's Choice in PTCL
- phase1A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
- phase2Cisplatin Plus Romidepsin & Nivolumab in Locally Recurrent or Metastatic Triple Negative Breast Cancer (TNBC)
- phase2Safety and Tolerance of Epigenetic and Immunomodulating Drugs Combined With Chemotherapeutics in Patients Suffering From Advanced Pancreatic Cancer
- phase1Romidepsin Maintenance After Allogeneic Stem Cell Transplantation
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that